Mexico Radiotherapy Market Report 2022 to 2030

Mexico Radiotherapy Market Analysis

$ 3999

By 2030, it is anticipated that the Mexico Radiotherapy Market will reach a value of $xx Mn from $104 Mn in 2022, growing at a CAGR of xx% during 2022-30. The Radiotherapy Therapeutics Market in Mexico is dominated by a few domestic players such as Tecnologia en Radioterapia, Medical Plus, and Grupo Gamma. The radiotherapy market in Mexico is segmented into different types, technologies, procedures, applications, and end-users. The major risk factors associated with awareness of radiotherapy shortage of skilled staff, government initiatives, and reimbursement policy. The demand for Mexico Radiotherapy is increasing on account of the rise in cancer cases in the country.

ID: IN10MXPH043 CATEGORY: Pharmaceuticals GEOGRAPHY: Mexico AUTHOR: Dr. Vishwa Modhia

Buy Now

Mexico Radiotherapy Market Analysis Summary

By 2030, it is anticipated that the Mexico Radiotherapy Market will reach a value of $xx Mn from $104 Mn in 2022, growing at a CAGR of xx% during 2022-30

In Latin America and the Caribbean, it is estimated that 1.5 Mn new cancer cases and 700,000 cancer deaths occur each year. Mexico is a developing country in North America having coastlines on the North Pacific Ocean, the Gulf of Mexico, and the Caribbean Sea. Mexico is the third most populous country in America, with 123 million people. In Mexico, 190,667 new cases of cancer are detected each year. The cancer burden in Latin America and the Caribbean is anticipated to increase by 67 percent by 2040, reaching 2.4 million new cases per year. Every Mexican hospital guarantees that any radiation emergency, such as oncological hemorrhage, cord compression, or pain, will be resolved within 24 hours or fewer.

People in Mexico sought alternative cancer remedies after established cancer therapy failed (or for stage 4 cancer). Mexican doctors are free to employ any cancer treatment breakthrough. In Mexico, tobacco smoking is the major cause of cancer mortality, accounting for one-third of all cancer deaths. Mexico's government spent 6.2% of its GDP on healthcare in 2020.

Mexico Radiotherapy Market Analysis

Market Dynamics

Market Growth Drivers Analysis

In 2020, the Mexican government developed the Comprehensive Cancer Care Program with the goal of boosting access to cancer medicines and enhancing the country's cancer care quality. The Mexican government has declared that in a country like Mexico, where cancer is the main cause of death among children, access to an adequate healthcare programme should be prioritised. Every year, thousands of cancer patients travel to Mexico to receive treatment that they cannot get elsewhere. Despite the fact that Mexico's technological facilities, people resources, and equipment amount are restricted, the lack of access to radiotherapy is compensated for by an enthusiastic community of radiation oncologists with an improving overall technical competency. These aspects could boost Mexico's, Radiotherapy Market.

Market restrains.

Mexico's radiation oncology facilities are expanding generally, with more radiotherapy centres and more precision technology than ever before, but there is a significant regional discrepancy in the distribution of the machines. These factors may deter new entrants into the Mexico Radiotherapy Market.

Competitive Landscape

Key Players

Tecnologia en Radioterapia. - Tecnologia en Radioterapia is a Mexican company that specializes in the design, manufacture, and installation of radiation therapy equipment such as linear accelerators, CT simulators, and brachytherapy systems
Medical Plus- Medical Plus is a Mexican company that distributes medical equipment, including radiation therapy equipment such as linear accelerators, CT simulators, and brachytherapy systems
Radiomedica- Radiomedica is a Mexican company that specializes in the distribution and maintenance of medical equipment, including radiation therapy equipment such as linear accelerators and CT simulators
Grupo Gamma - Grupo Gamma is a Mexican company that provides radiation therapy services, including the use of linear accelerators and brachytherapy equipment, in partnership with hospitals and clinics throughout Mexico

Notable Recent Deals

April 2023: The International Conference on Oncology (ICO) will be held in Cancun, Mexico this year. Researchers, scientists, academics, engineers, academic, scientific, and university practitioners are welcome to attend events, meetings, seminars, congresses, workshops, summits, and symposiums.

Healthcare Policies and Reimbursement Scenarios

In Mexico, the regulations and reimbursement of radiotherapy are overseen by the Ministry of Health (Secretaría de Salud) and the National Commission for the Protection against Sanitary Risks (Comisión Federal para la Protección contra Riesgos Sanitarios). The Mexican Society of Radiation Oncology (SMRO) is the main professional organization for radiation oncologists in Mexico and works closely with the Ministry of Health to develop guidelines and standards of practice for radiotherapy. The Instituto Mexicano del Seguro Social (IMSS) is the largest public health insurance provider in Mexico and covers the cost of radiotherapy for eligible patients.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Radiotherapy Segmentation

By Type (Revenue, USD Billion):

External Beam Radiation Therapy
Linear Accelerators
Compact Advanced Radiotherapy Systems
Cyberknife
Gamma Knife
?Tomotherapy
Proton Therapy
Cyclotron
?Synchrotron
Internal Beam Radiation Therapy
Brachytherapy
Seeds
Applicators and Afterloaders
Electronic Brachytherapy
Systemic Radiation Therapy
?Others

?By Technology (Revenue, USD Billion):

External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-Guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy (SRT)
3D Conformal Radiation Therapy (3D-CRT)
Particle Therapy
Internal Beam Radiotherapy
Brachytherapy
High-Dose Rate Brachytherapy
Low-Dose Rate Brachytherapy
Image-Guided Brachytherapy
Pulse-Dose Rate Brachytherapy
Systemic Radiation Therapy
Intravenous Radiotherapy
Oral Radiotherapy?

By Application (Revenue, USD Billion):

Breast Cancer
Cervical Cancer
Colon and rectum Cancers
Stomach Cancer
Lung Cancer
Prostate Cancer
Skin Cancer
Liver Cancer
Other types of cancer

By End User (Revenue, USD Billion):

Hospitals
Radiotherapy Centers & Ambulatory Surgery Centers
?Cancer Research Institutes

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.